findmyKOL
Clinical trialNCT01468350CompletedPhase 1Interventional

Safety and Tolerability of Dalfampridine in Subjects With Cerebral Palsy

SponsorAcorda TherapeuticsEnrollment35Cerebral Palsy (CP)
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Alabama at Birmingham

    Birmingham, Alabama, United States

  • Rancho Los Amigos National Rehabilitation Center

    Downey, California, United States

  • Ucla/orthopaedic Hospital Center for Cerebral Palsy

    Los Angeles, California, United States

  • Rady Children'S Hospital San Diego

    San Diego, California, United States

  • Rehabilitation Institute of Chicago

    Chicago, Illinois, United States

  • Kennedy Krieger Institute at Johns Hopkins University

    Baltimore, Maryland, United States

  • Detroit Clinical Research Center

    Farmington Hills, Michigan, United States

  • Gillette Children'S Specialty Healthcare

    Saint Paul, Minnesota, United States

  • University of Missouri at Columbia

    Columbia, Missouri, United States

  • Cleveland Clinic

    Cleveland, Ohio, United States

  • Swedish Medical Center

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Dec 2011
Primary completion
31 Jan 2013
Completion
31 Mar 2013
Last update posted
24 Jun 2014
Registered enrollment
35
Registry id
NCT01468350

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.